A new chemotherapy‐free regimen of olverembatinib in combination with venetoclax and dexamethasone for newly diagnosed Ph+ acute lymphoblastic leukemia: Preliminary outcomes of a prospective study
Authors:
Published:
0000-00-00
DOI:
HTTPS://DOI.ORG/10.1002/ajh.27289
Keywords:
Abstract:
Source: